Cell-specific aptamers as potential drugs in therapeutic applications: A review of current progress

J Control Release. 2022 Jun:346:405-420. doi: 10.1016/j.jconrel.2022.04.039. Epub 2022 May 4.

Abstract

Cell-specific aptamers are a promising emerging player in the field of disease therapy. This paper reviews the multidimensional research progress made in terms of their classification, modification, and application. Based on the target location of cell-specific aptamers, it is defined and classified cell-specific aptamers into three groups including aptamers for cell surface markers, aptamers for intracellular components, and aptamers for extracellular components. Moreover, the modification methods of aptamers to achieve improved stability and affinity are concluded. In addition, recent advances in the application of cell-specific aptamers are discussed, mainly focusing on the increasing research attraction of cell state improving helpers and cell recruitment mediators in the improvement of cellular microenvironments to achieve successful disease therapy. This review also highlights 11 types of clinical aptamer drugs. Finally, the challenges and future directions of potential clinical applications are presented. In summary, we believe that cell-specific aptamers are promising drugs in disease therapy.

Keywords: Application; Cell-specific aptamers; Classification; Disease therapy; Modification.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aptamers, Nucleotide* / metabolism
  • Aptamers, Nucleotide* / therapeutic use
  • Drug Delivery Systems

Substances

  • Aptamers, Nucleotide